Literature DB >> 3473654

Serological profiles in subgroups of patients with Sjögren's syndrome.

M N Manoussakis, A G Tzioufas, P J Pange, H M Moutsopoulos.   

Abstract

The serological profiles of 54 patients with primary Sjögren's syndrome (pSS) and 92 rheumatoid arthritis (RA) patients with or without secondary SS (sSS), were retrospectively evaluated and correlated with: different subgroups of SS, degree of minor salivary gland biopsy lymphocytic infiltrates and the presence of glandular and extraglandular manifestations. Antibodies to nuclear antigens (ANA), anti-Ro(SSA) and anti-La(SSB) as well as rheumatoid factor (RF) correlate with definite pSS, while in RA, ANA and anti-Ro(SSA) are associated with the presence of sSS and anti-La(SSB) is practically absent. In pSS patients, the incidence of anti-Ro(SSA) and anti-La(SSB), as well as the titers of ANA and RF, correlate with the degree of salivary lymphocytic infiltrates in class 1+ to 3+. In class 4+, a substantial decrease of the autoantibodies is noted. In pSS patients, anti-Ro(SSA) and anti-La(SSB) correlate with earlier disease onset and longer disease duration, recurrent parotid gland enlargement (RPGE), as well as with the presence of extraglandular manifestations (extr. manif.) particularly splenomegaly/lymphadenopathy and vasculitis. Anti-Ro(SSA) correlates with positive Schirmer's test, ANA with decreased parotid flow rate and extr. manif., while RF correlates with RPGE and subjective xerostomia. In RA patients, autoantibodies were predominantly found in the presence of features of eye dryness: ANA correlate with positive Schirmer's test, Rose-Bengal stain and subjective xerophthalmia, the latter also correlated with anti-Ro(SSA). This study, re-emphasizes the diagnostic significance of autoantibodies for SS, and possibly contributes in the delineation of biological processes in this disease.

Entities:  

Mesh:

Year:  1986        PMID: 3473654

Source DB:  PubMed          Journal:  Scand J Rheumatol Suppl        ISSN: 0301-3847


  19 in total

1.  Prevalence of anti-cyclic citrullinated peptide and anti-keratin antibodies in patients with primary Sjögren's syndrome.

Authors:  J-E Gottenberg; S Mignot; P Nicaise-Rolland; J Cohen-Solal; F Aucouturier; J Goetz; C Labarre; O Meyer; J Sibilia; X Mariette
Journal:  Ann Rheum Dis       Date:  2004-07-01       Impact factor: 19.103

Review 2.  Anti-Ro (SSA)/La (SSB) antibodies and Sjögren's syndrome.

Authors:  H M Moutsopoulos; L V Zerva
Journal:  Clin Rheumatol       Date:  1990-03       Impact factor: 2.980

3.  Lymphocytic alveolitis: A surprising index of poor prognosis in patients with primary Sjogren's syndrome.

Authors:  Y A Dalavanga; P V Voulgari; A N Georgiadis; C Leontaridi; S Katsenos; M Vassiliou; A A Drosos; S H Constantopoulos
Journal:  Rheumatol Int       Date:  2005-12-13       Impact factor: 2.631

4.  [Sjögren syndrome].

Authors:  José V Sorlí; Ismael Ejarque Doménech; F J Valderrama Zurián; Vicente Martín Gutiérrez; Mercedes Mingarro Castillo; Miguel García-Ribes; Ramón Ortiz Uriarte
Journal:  Aten Primaria       Date:  2009-05-15       Impact factor: 1.137

5.  The value of synthetic linear epitope analogues of La/SSB for the detection of autoantibodies to La/SSB; specificity, sensitivity and comparison of methods.

Authors:  E E Yiannaki; A G Tzioufas; M Bachmann; J Hantoumi; V Tsikaris; M Sakarellos-Daitsiotis; C Sakarellos; H M Moutsopoulos
Journal:  Clin Exp Immunol       Date:  1998-04       Impact factor: 4.330

6.  Selective polyclonal increase of immunoglobulin G1 subclass: a link with Sjögren's syndrome.

Authors:  E M Hay; A J Freemont; R A Kay; R M Bernstein; P J Holt; R S Pumphrey
Journal:  Ann Rheum Dis       Date:  1990-06       Impact factor: 19.103

7.  The clinical significance of anti-cyclic citrullinated peptide antibody in primary Sjögren syndrome.

Authors:  So-Mi Kim; Eugene Park; Jung-Hwa Lee; Sang-Heon Lee; Hae-Rim Kim
Journal:  Rheumatol Int       Date:  2011-12-29       Impact factor: 2.631

Review 8.  Sjogren syndrome in childhood: report of two cases.

Authors:  A Siamopoulou-Mavridou; A A Drosos; A P Andonopoulos
Journal:  Eur J Pediatr       Date:  1989-04       Impact factor: 3.183

9.  Anti-Ro/SSA and anti-La/SSB autoantibodies in the tear fluid of patients with Sjögren's syndrome.

Authors:  E Toker; S Yavuz; H Direskeneli
Journal:  Br J Ophthalmol       Date:  2004-03       Impact factor: 4.638

10.  The role of inflammation and antiinflammation therapies in keratoconjunctivitis sicca.

Authors:  Koray Gumus; Dwight H Cavanagh
Journal:  Clin Ophthalmol       Date:  2009-06-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.